Personalis, Inc. (PSNL)
NASDAQ: PSNL · IEX Real-Time Price · USD
1.260
+0.010 (0.80%)
At close: Apr 26, 2024, 3:59 PM
1.265
+0.005 (0.40%)
After-hours: Apr 26, 2024, 4:00 PM EDT
Personalis Market Cap
Personalis has a market cap or net worth of $63.89 million as of April 26, 2024. Its market cap has decreased by -48.44% in one year.
Market Cap
63.89M
Enterprise Value
-12.17M
1-Year Change
-48.44%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $811.90M to $63.89M, a decrease of -92.13%. That is a compound annual growth rate of -40.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 63.10M | -3.96% |
Apr 24, 2024 | 65.70M | -5.74% |
Apr 23, 2024 | 69.70M | 9.59% |
Apr 22, 2024 | 63.60M | -2.45% |
Apr 19, 2024 | 65.20M | 6.71% |
Apr 18, 2024 | 61.10M | 0.83% |
Apr 17, 2024 | 60.60M | -3.19% |
Apr 16, 2024 | 62.60M | -1.57% |
Apr 15, 2024 | 63.60M | -1.24% |
Apr 12, 2024 | 64.40M | -6.94% |
Apr 11, 2024 | 69.20M | -0.72% |
Apr 10, 2024 | 69.70M | -4.78% |
Apr 9, 2024 | 73.20M | 2.81% |
Apr 8, 2024 | 71.20M | 1.42% |
Apr 5, 2024 | 70.20M | -0.71% |
Apr 4, 2024 | 70.70M | 3.67% |
Apr 3, 2024 | 68.20M | -1.45% |
Apr 2, 2024 | 69.20M | -4.16% |
Apr 1, 2024 | 72.20M | -4.12% |
Mar 28, 2024 | 75.30M | 2.87% |
Mar 27, 2024 | 73.20M | 1.39% |
Mar 26, 2024 | 72.20M | -0.69% |
Mar 25, 2024 | 72.70M | 1.39% |
Mar 22, 2024 | 71.70M | -2.71% |
Mar 21, 2024 | 73.70M | -3.41% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AN2 Therapeutics | 70.56M |
Anebulo Pharmaceuticals | 70.28M |
Celularity | 69.92M |
Instil Bio | 69.92M |
VolitionRx | 69.76M |
Landos Biopharma | 69.09M |
Silver Spike Investment | 69.04M |
Champions Oncology | 68.92M |